The Medicare GLP-1 Bridge took effect July 1, 2026, and we are scheduling Medicare eligibility visits now
The company will start regulatory filings for these markets in early 2026 and expects gains to start coming in from calendar year 2027
Cost Comparison Summary The availability of compounded semaglutide provides an access option that doesnt exist for dulaglutide, potentially making semaglutide more accessible for patients without insurance coverage
When clinically appropriate, providers may recommend options such as GLP-1 medications as part of a broader care plan
While both medications lead to significant weight loss, tirzepatides dual action on GIP and GLP-1 receptors may contribute to its higher efficacy
We now know that patients frequently discontinue GLP-1 therapy within months, negating long-term benefits, and also struggle to meet the requirements of lifestyle changes that are prescribed alongside the medication